Jun Liao

Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M Mutational Status

Lanlan Pang, Likun Chen, Li Zhang, 2022, Cancer control : journal of the Moffitt Cancer Center.

Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta-analysis

Lanlan Pang, Li Zhang, W. Fang, 2022, BMJ Open.

Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients.

Lanlan Pang, L. Zeng, W. Fang, 2022, Lung cancer.

Efficacy and potential resistance mechanisms of afatinib in advanced non–small cell lung cancer patients with EGFR G719X/L861Q/S768I

Lanlan Pang, W. Fang, P. Deng, 2022, Cancer.

OTT_A_335217 5297..5307

Lanlan Pang, W. Fang, Jun Liao, 2021 .

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

Lanlan Pang, W. Fang, Jun Liao, 2021, OncoTargets and therapy.

Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy

Lanlan Pang, W. Fang, L. Zhang, 2023, BMC Cancer.

Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma

Lanlan Pang, W. Fang, L. Zhang, 2023, International journal of cancer.

Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma

W. Fang, Yu-xiang Ma, Yun-peng Yang, 2023, Cancer control : journal of the Moffitt Cancer Center.